Zealand Set To Take On Lilly After Zegalogue US Approval
Green Light For Hypoglycemia Drug Is A First For Danish Firm
Despite being third to market behind Lilly’s Baqsimi and Xeris’s Gvoke to treat emergency episodes of hypoglycemia, Zealand is confident of a successful US launch for Zegalogue (dasiglucagon).
